Form 8-K - Current report:
SEC Accession No. 0000950170-25-099891
Filing Date
2025-07-30
Accepted
2025-07-30 08:25:54
Documents
34
Period of Report
2025-07-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nams-20250730.htm   iXBRL 8-K 95313
2 EX-99.1 nams-ex99_1.htm EX-99.1 65382
3 EX-99.2 nams-ex99_2.htm EX-99.2 30524
4 GRAPHIC nams-ex99_2s1.jpg GRAPHIC 340753
5 GRAPHIC nams-ex99_2s2.jpg GRAPHIC 945725
6 GRAPHIC nams-ex99_2s3.jpg GRAPHIC 311301
7 GRAPHIC nams-ex99_2s4.jpg GRAPHIC 408367
8 GRAPHIC nams-ex99_2s5.jpg GRAPHIC 366599
9 GRAPHIC nams-ex99_2s6.jpg GRAPHIC 284356
10 GRAPHIC nams-ex99_2s7.jpg GRAPHIC 438025
11 GRAPHIC nams-ex99_2s8.jpg GRAPHIC 400450
12 GRAPHIC nams-ex99_2s9.jpg GRAPHIC 387068
13 GRAPHIC nams-ex99_2s10.jpg GRAPHIC 267973
14 GRAPHIC nams-ex99_2s11.jpg GRAPHIC 339329
15 GRAPHIC nams-ex99_2s12.jpg GRAPHIC 256714
16 GRAPHIC nams-ex99_2s13.jpg GRAPHIC 233825
17 GRAPHIC nams-ex99_2s14.jpg GRAPHIC 255429
18 GRAPHIC nams-ex99_2s15.jpg GRAPHIC 319226
19 GRAPHIC nams-ex99_2s16.jpg GRAPHIC 279882
20 GRAPHIC nams-ex99_2s17.jpg GRAPHIC 249053
21 GRAPHIC nams-ex99_2s18.jpg GRAPHIC 351466
22 GRAPHIC nams-ex99_2s19.jpg GRAPHIC 274964
23 GRAPHIC nams-ex99_2s20.jpg GRAPHIC 243701
24 GRAPHIC nams-ex99_2s21.jpg GRAPHIC 206830
25 GRAPHIC nams-ex99_2s22.jpg GRAPHIC 504310
  Complete submission text file 0000950170-25-099891.txt   10927591

Data Files

Seq Description Document Type Size
26 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nams-20250730.xsd EX-101.SCH 55020
36 EXTRACTED XBRL INSTANCE DOCUMENT nams-20250730_htm.xml XML 6274
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 251164069
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)